Trouble viewing? Click here.

Webinar: Highly-Personalized Therapies & Cancer Management

Wednesday, January 25, 2023 | Now Available On-Demand

Through collaborations between biopharma and diagnostic developers the field of oncology is advancing to ensure highly-personalized therapies and diagnostics are a part of the next gold standard of care. In this webinar, you'll learn about a case study pursued in collaboration with Geneos Therapeutics and Personalis to utilize a tumor-informed ctDNA assay to retrospectively analyze clinical response to a class of personalized immunotherapies developed against tumor-specific neoantigens in advanced hepatocellular cancer (HCC) patients.